Evidence map›Paper›PMID 31397047›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2020

Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.

Zihao Zheng, Aisha M Mergaert, Lauren M Fahmy, Mandar Bawadekar, Caitlyn L Holmes, Irene M Ong, Alan J Bridges, Michael A Newton, Miriam A Shelef

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zihao ZhengUniversity of Wisconsin-Madison.
Aisha M MergaertUniversity of Wisconsin-Madison.
Lauren M FahmyUniversity of Wisconsin-Madison.
Mandar BawadekarUniversity of Wisconsin-Madison.
Caitlyn L HolmesUniversity of Wisconsin-Madison.
Irene M OngUniversity of Wisconsin-Madison and University of Wisconsin Carbone Comprehensive Cancer Center.
Alan J BridgesUniversity of Wisconsin-Madison and William S. Middleton Memorial Veterans Hospital.
Michael A NewtonUniversity of Wisconsin-Madison.
Miriam A ShelefUniversity of Wisconsin-Madison and William S. Middleton Memorial Veterans Hospital.ORCID 0000-0002-8842-0303
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
TrainingU54AI117924 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI CRAVEN, MARK W. · 2014 to 2018
$11.3M
RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
PAD2 and PAD4 in Citrullination, Autoantibodies, and Rheumatoid ArthritisK08AR065500 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI SHELEF, MIRIAM ANNE · 2014 to 2018
$690k
Congressionally Directed Medical Research Programs PR170847Doris Duke Charitable Foundation 2015099NCI NIH HHS P30 CA014520NHLBI NIH HHS T32 HL007899NIAID NIH HHS U54 AI117924NIAMS NIH HHS K08 AR065500University of Wisconsin - Madison Office of the Chancellor and the Vice Chancellor for Research and Graduate Education with funding from the Wisconsin Alumni Research FoundationUniversity of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program
6 · The paper itself

Abstract

objectiveAnti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are commonly present in rheumatoid arthritis (RA) without a clear rationale for their coexistence. Moreover, autoantibodies develop against proteins with different posttranslational modifications and native proteins without obvious unifying characteristics of the antigens. We undertook this study to broadly evaluate autoantibody binding in seronegative and seropositive RA to identify novel features of reactivity.

methodsAn array was created using a total of 172,828 native peptides, citrulline-containing peptides, and homocitrulline-containing peptides derived primarily from proteins citrullinated in the rheumatoid joint. IgG and IgM binding to peptides were compared between cyclic citrullinated peptide (CCP)-positive RF+, CCP+RF-, CCP-RF+, and CCP-RF- serum from RA patients (n = 48) and controls (n = 12). IgG-bound and endogenously citrullinated peptides were analyzed for amino acid patterns and predictors of intrinsic disorder, i.e., unstable 3-dimensional structure. Binding to IgG-derived peptides was specifically evaluated. Enzyme-linked immunosorbent assay confirmed key results.

resultsBroadly, CCP+RF+ patients had high citrulline-specific IgG binding to array peptides and CCP+RF- and CCP-RF+ patients had modest citrulline-specific IgG binding (median Z scores 3.02, 1.42, and 0.75, respectively; P < 0.0001). All RA groups had low homocitrulline-specific binding. CCP+RF+ patients had moderate IgG binding to native peptides (median Z score 2.38; P < 0.0001). The highest IgG binding was to citrulline-containing peptides, irrespective of protein identity, especially if citrulline was adjacent to glycine or serine, motifs also seen in endogenous citrullination in the rheumatoid joint. Highly bound peptides had multiple features predictive of disorder. IgG from CCP+RF+ patients targeted citrulline-containing IgG-derived peptides.

conclusionDisordered antigens, which are frequently citrullinated, and common epitopes for ACPAs and RF are potentially unifying features for RA autoantibodies.

Indexed as

Anti-Citrullinated Protein AntibodiesArthritis, RheumatoidAutoantigensEpitopesFemaleHumansMaleRheumatoid FactorAnti-Citrullinated Protein AntibodiesAutoantigensEpitopesRheumatoid Factor

Identifiers

PMID31397047
PMCPMC6994383
OpenAlexW2967411352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.